SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): September 25, 2013
AIRWARE LABS CORP.
(Exact name of registrant as specified in its charter)
| Delaware | | 000-54730 | | 98-0665018 |
| (State or other jurisdiction | | (Commission File Number) | | (IRS Employer |
| of Incorporation) | | | | Identification Number) |
| | | | | |
c/o Jeffrey Rassas
8399 E. Indian School Rd.,Suite 202
Scottsdale, AZ 85251
Tel. 480-463-4246
(Address, including zip code, and telephone number, including area code,
of registrant's principal executive offices)
c/o Delaware Intercorp, Inc.
113 Barksdale Professional Center
Newark, DE 19711
Tel. 302-266-9367
(Name, address, including zip code, and telephone number,
Including area code, of agent for service)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
AIRWARE LABS CORP.
Form 8-K
Current Report
| ITEM 5.02 | DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS |
Appointment
On September 25, 2013, Dr. Lorrie Henderson (“Dr. Henderson”) was appointed to serve as the Chief Operating Officer of Airware Labs Corp. (the “Company”) and has accepted such appointment. The biography for Dr. Henderson is set forth below.
Dr. Lorrie Henderson–Dr. Lorrie Henderson, PhD, MBA, age 51, has been appointed Chief Operating Officer of AirWare Labs. In this role, Dr. Henderson will work with AirWare Labs to further the strategy, and to increase brand awareness, profitability, and shareholder value globally. Dr. Henderson has over 25 years of leadership experience in the field of Healthcare/Behavioral Health. He has held the top leadership positions of President/Chief Executive Officer, Chief Operating Officer, Executive Vice-President, and Executive Director. Dr. Henderson has served on multiple national boards and has conducted research, as well as published and presented numerous scientific peer-reviewed journal articles on a variety of topics. Dr. Henderson earned his bachelor’s degree from Florida Atlantic University, his master’s degree from Florida International University, a Ph.D. from Barry University in Florida, and an MBA, summa cum laude, from Jones International University.
Family Relationships
Mr. Hendersonis not related to any officer or Director of the Company.
Related Party Transactions
There are no related party transactions reportable under Item 5.02 of Form 8-K and Item 404(a) of Regulation S-K.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | | | | |
| | | |
| | AIRWARE LABS CORP. |
| Date: September 25, 2013 | By: | /s/ Jeffrey Rassas | |
| | | Jeffrey Rassas |
| | | Chief Executive Officer |
